Brown-Forman Corporation (BF-B): what the price assumes

In the published model solve dated 2026-Q2, anchored at $27.22, Brown-Forman Corporation (BF-B) is priced for -4.4% growth. boothcheck publishes no house fair value, target price, or buy/sell rating; individual model outputs and user-controlled scenarios are analytical inputs, not Boothcheck targets. Narrative composed 2026-07-25.

Generated: 2026-08-30 · Source: https://boothcheck.com/report/BF-B

Headline

What The Price Assumes (Inversion)

The assumption today's price embeds, recovered by inverting the valuation.

The operating-margin figure is value-band context at year 12: derived from the framework's value band, a separate calculation — not part of the priced-in solve.

Solve inputs: computed at a 7.8% cost of capital with 4% terminal growth over a 5-year stage.

How unusual the bet is: within-range (limited comparison data)

Valuation X-Ray

The price is justified by relative-multiple; earnings-power land below the price.

How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.

Families that justify the price: Relative Families that call it expensive: Earnings

The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 7.7%); the inversion above states its own rate.

Per-Model Detail (n=15)

Economic-Unit Decomposition (Sum Of The Parts)

Only one reportable economic unit is present in the current topology source. Consolidated operating lenses remain available, but there is no multi-unit decomposition.

No total common-equity value is stated. One or more material units lack a supported unit value. The displayed values are an indicative subtotal; consolidated debt and cash cannot be applied to a fraction of the company.

Solvency

Bullet Takeaways

• Price and mix, not volume, are holding this business up: fiscal 2025 net sales of $4.0 billion fell 5% while "Volume declined 7% driven by the negative effect of acquisitions and divestitures", and the pattern has not reversed since.
• Management's own fiscal 2027 outlook is roughly flat organic net sales with organic operating income lower by 3% to 5%, which means the base case from inside the building is another year without growth.
• The tell to watch is geography: Canada's net sales fell 14% in fiscal 2025 on American whiskey volume declines while Brazil's rose 12%, and which of those two directions dominates decides the next several years.

Bull Case

One number decides this company, and it is not the multiple. It is volume. In fiscal 2025 net sales came to $4.0 billion, down 5%, and the composition of that decline is the whole argument: "Volume declined 7% driven by the negative effect of acquisitions and divestitures", and favourable price and mix absorbed a good part of the damage. A business that can lose seven points of volume and give up only five points of revenue is charging more per bottle and selling a better bottle. Stabilize volume anywhere near flat and the same pricing behaviour turns a shrinking revenue line into a growing one, without a single new consumer being recruited.

There are brands underneath that capable of doing it. The annual filing is direct about where the growth is meant to come from beyond the flagship: "we expect strong worldwide growth from our other whiskey brands, particularly Woodford Reserve and Old Forester. Woodford Reserve is the leading super-premium American whiskey globally". Gentleman Jack net sales rose 4% in fiscal 2025 on higher prices and volumes in Türkiye and volumetric growth in Germany. Brazil rose 12% on the Jack Daniel's family and expanded distribution. These are small numbers against a $12.1 billion company, and that is rather the point: the portfolio does not need a new flagship, it needs several existing brands to keep doing what they are already doing in markets where drinking-age populations are still growing.

The strategy behind it is unglamorous and consistent. The company says it intends to "foster this growth by emphasizing fast-growing spirits categories, continuing product and packaging innovation, and building brands within growing consumer segments", and the ready-to-drink line is the visible version of that: bulk whiskey shipments have been growing to supply Jack Daniel's and Coca-Cola canned products, which converts the same liquid into a format that reaches drinkers who were never going to buy a bottle. Ready-to-drink is already 14% of the revenue mix and tequila another 6%.

Set against the cohort, roughly flat is doing well. Over the comparable window Constellation Brands (STZ) reported revenue down 10.2%, Molson Coors (TAP) down 5.1% and Boston Beer (SAM) down 4.6% on their own filings, while McCormick (MKC) and Keurig Dr Pepper (KDP) grew 9.5% and 9.2% in categories that are not fighting the same consumption headwind. The alcohol shelf is having a hard cycle and this company is having a less hard one than most of the names that sit near it.

Then there is the inventory, which is the strangest asset in consumer staples and the most under-appreciated. Whiskey sold this year was distilled and barrelled years ago, at costs incurred years ago, and sells at today's prices. The company carries that maturing stock, funds it, and waits. It is a working-capital drag in every quarter until the moment it is not, and it is also the reason a competitor cannot decide to enter super-premium American whiskey next Tuesday. The barrels are the barrier.

Bear Case

Moat erosion in a spirits company shows up first at the point where the bottle changes hands, not at the distillery. The annual filing puts the problem plainly: "If the buying power of these large retail customers continues to increase, it could negatively affect our financial results." It goes on to concede that "we nevertheless face a risk that continuing consolidation of large beverage alcohol companies could put us at a" disadvantage. A brand that must be stocked is powerful. A brand that must be stocked by four buyers who each carry a competing American whiskey and a private-label alternative is somewhat less so, and shelf economics move slowly and then all at once.

The geographic pattern says the erosion is already underway in the places that matter most for profit. Canada's net sales fell 14% in fiscal 2025 on volumetric declines across the American whiskey portfolio. Developed international markets have been the drag repeatedly, with South Korea, Germany and the United Kingdom named in successive years. Emerging markets have grown, and Brazil's 12% gain is real, but emerging-market volume carries lower absolute margin dollars and more currency risk than a case sold in Ontario. Whiskey is 74% of the revenue mix; there is nowhere for a whiskey problem to hide inside this portfolio.

The aged inventory that makes the moat also makes the trap. Filling barrels is a bet on demand several years forward, and the company is explicit that "The forecasting strategies we use to balance product supply with fluctuations in consumer demand may not be effective for particular years or products", warning that "not having our products in the market consistently may adversely affect our brand equity and future sales". The failure runs in both directions. Too little liquid and the brand goes missing from the shelf; too much and the company owns years of whiskey distilled for a demand curve that did not arrive, which it can only clear by discounting the one thing it must never discount. Reported operating income fell 22% in fiscal 2025, and the following year brought impairments and a restructuring programme rather than a recovery.

Where does that leave the price. Not in the usual bear position, and this is worth being honest about. The market is already paying a low multiple. Run a discounted view at a 7.8% cost of capital and an operating profit shrinking 5% a year would still support more than the current quote. Management guides fiscal 2027 to an organic operating income decline of 3% to 5%. So the bear thesis cannot be that the shares are expensive. It has to be that the decline runs longer than the market's five-year window assumes, and that is precisely the variable nobody in this industry has ever forecast well. A cheap multiple applied to a profit stream that falls for eight years instead of five is not a bargain, it is a slow leak.

The balance sheet does not force the issue and does not solve it either. Net debt sits near 2.2 billion dollars against liquid assets of 308 million dollars, and interest is covered many times over from operating profit, so nothing here is fragile. What the balance sheet cannot do is release the inventory. Working capital in a whiskey business is committed in barrels that cannot be turned into cash on demand at a price the brand survives, which means the flexibility that a leveraged consumer company would normally have in a downturn is simply not available here.

Valuation

Only one family of methods lands anywhere near this price, and it is the comparison to other companies. Peer multiples centre about 3% below the price, which is as close to agreement as this exercise usually gets. Everything else sits further away, and the direction is consistent: the price stands about a third above where the asset-value methods and the forward-growth methods centre, and about 64% above the earnings-power family, which capitalizes the cash the business throws off this year and credits it with nothing further.

Invert the price instead and the picture is unusual for a consumer staple. The market is paying roughly 11.2 times a year of company-wide operating income, low enough that a discounted view at a 7.8% cost of capital across a five-year stage would support more than the current quote even with operating profit shrinking 5% a year. Very few branded consumer businesses are priced for shrinkage. This one is, and management's own fiscal 2027 outlook, organic net sales "to be approximately flat" with organic operating income declining "in the 3% to 5% range", is close enough to that embedded assumption that the two are barely arguing.

The reconciliation between those two readings is where the analytical work is. A discounted view credits a terminal value that assumes the business is still standing decades out, so it forgives a great deal of near-term weakness. The earnings-power methods refuse to credit anything beyond the current year, which is why they land so far below the price. Neither is wrong. They are answering different questions, and the gap between them is exactly the value of believing that fiscal 2026 was a trough rather than a new plateau.

Solvency is not the swing factor. Net debt of about 2.2 billion dollars is covered many times over at the interest line out of operating profit, the company is not consuming cash, and the share count has come down about 0.9% a year since January 2022. The dividend is funded from earnings rather than borrowings, with diluted earnings of $1.53 a share in fiscal 2026 against a payout that runs a little over 92 cents a year.

Which leaves the timing question the methods cannot settle. Every one of the static approaches capitalizes a year that included impairment charges, restructuring costs, and the end of a distribution relationship, and treats that year as the run rate for eternity. If it is the run rate, the price is roughly right and slightly generous. If it is a trough in a category cycle that has turned many times before, the same methods will be capitalizing a much larger number in three years, and the price paid today will look like it was set during the worst possible month to be measuring.

Catalysts

Start with the guidance, because it is unusually specific and it frames everything else. Alongside the fiscal 2026 annual filing, management set out its expectations for fiscal 2027: organic net sales approximately flat, organic operating income lower by 3% to 5%, an effective tax rate of approximately 20% to 22%, and capital expenditures of $60 to $70 million. A capital budget that small against a business this size says the company sees no project worth funding beyond maintenance, which is a statement about the demand environment as much as about the balance sheet.

The results that guidance came with landed on June 4, 2026. Full-year net sales were $3.9 billion, down 1% as reported and flat on an organic basis, and diluted earnings came to $1.53 a share, down 17%. The fourth quarter told a sharper version of the same story: net sales up 2% to $912 million, while reported operating income fell 53% to $96 million and was flat organically. Impairment and restructuring items account for the distance between those two operating income figures.

Analysts have adjusted downward rather than argued. Barclays moved its rating to Equal Weight from Overweight on June 25, 2026, part of a run of target reductions that followed the print. The dividend has been unaffected, with the quarterly payment of 23.1 cents a share going ex on June 10, 2026. The next genuine information event is the fiscal first-quarter report, and the single most useful line in it will be the split between volume and price. Everything in the fiscal 2027 guide depends on whether pricing can keep covering for volume for a fourth consecutive year.

Peer Cohorts (Per Segment, With Filing Citations)

Brown-Forman (consolidated) (reported)

• DEO (DIAGEO plc)
• FY2025 20-F: …products for other group companies and includes the production sites in the United Kingdom, Ireland, Italy, Guatemala and Mexico, as well as comprises the global procurement function, is considered a key intersegmental operation instead of a separate operating segment . 156 Diageo Form 20-F 2025 FINANCIAL STATEMENTS…
• FY2025 20-F: June 2025, based on criteria established in Internal Control - Integrated Framework (2013) issued by the COSO. Basis for Opinions The Company's management is responsible for these consolidated financial statements, for maintaining effective internal control over financial reporting, and for its assessment of the…
• STZ (CONSTELLATION BRANDS, INC.)
• FY2025 10-K: …unconsolidated investments within our consolidated results for the year ended February 28, 2025. Future impairments, if any, will also be reported in income (loss) from unconsolidated investments within our consolidated results. In April 2024, we elected to convert our 17.1 million Canopy common shares into…
• FY2025 10-K: …assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company's assets that could have a material effect on the financial statements. Constellation Brands, Inc. FY 2025 Form 10-K #WORTHREACHINGFOR I 57 PART II ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA…
• SAM (THE BOSTON BEER COMPANY, INC.)
• FY2025 10-K: …Samuel A. Calagione III and Mariah D. Calagione (incorporated by reference to Exhibit 2.2 to the Company's Form 8-K filed on May 9, 2019). 2.3 Membership Unit Purchase Agreement, dated as of May 8, 2019, by and among The Boston Beer Company, Inc. and DFH Investors LLC (incorporated by reference to Exhibit 2.3 to the…
• FY2025 10-K: ) Retained earnings 147,744 240,315 Total stockholders' equity 846,280 916,187 Total liabilities and stockholders' equity $ 1,193,595 $ 1,250,018 The accompanying notes are an integral part of these consolidated financial statements 41 THE BOSTON BEER COMPANY, INC. AND SUBSIDIARIES CONSOLIDATED STATEMENTS O F…
• TAP (MOLSON COORS BEVERAGE CO)
• FY2025 10-K: This guidance is effective for us starting with our annual report for the year ending December 31, 2027 and the subsequent interim periods, with prospective and retrospective application allowed and early adoption permitted. We are assessing the impact of the ASU, including the timing and method of adoption, however,…
• FY2025 10-K: …on the consolidated balance sheets. The affiliate accounts payable and affiliate accounts receivable related to trade receivables and payables for sales to external customers and costs incurred were offset by administrative fees charged and paid by MCBC (which may be in a payable or receivable position depending on…
• KDP (Keurig Dr Pepper Inc.)
• FY2025 10-K: …table summarizes our long-term obligations: December 31, (in millions) 2025 2024 Notes $ 13,931 $ 12,948 Term loan - 990 Less: current portion of long-term obligations ( 895 ) ( 1,026 ) Long-term obligations $ 13,036 $ 12,912 The following table summarizes our short-term borrowings and current portion of long-term…
• FY2025 10-K: SATION Information required to be set forth hereunder has been omitted and will be incorporated by reference, when filed, from our Proxy Statement. ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS Information required to be set forth hereunder has been omitted and…
• FIZZ (National Beverage Corp.)
• FY2025 10-K: …and are reported elsewhere in the consolidated financial statements. Other segment items include other selling and general administrative costs (primarily consisting of compensation-related and other overhead costs), other income (expense), net which includes interest income and interest expense, and provision for…
• FY2025 10-K: …year ended May 3, 2025, and the related notes (collectively referred to as the "consolidated financial statements"). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company as of May 3, 2025, and the results of its operations and its cash…
• MKC (McCORMICK & COMPANY, INCORPORATED)
• FY2025 10-K: …(the Company) as of November 30, 2025 and 2024, the related consolidated income statements, statements of comprehensive income, cash flow statements and statements of shareholders' equity for each of the three years in the period ended November 30, 2025, and the related notes and financial statement schedule listed…
• FY2025 10-K: …reference from Exhibit 4.1 of McCormick's Form 10-Q for the quarter ended August 31, 2001, File No. 1-14920, as filed with the Securities and Exchange Commission on October 12, 2001. (iii) Indenture dated July 8, 2011 between McCormick and U.S. Bank National Association, incorporated by reference from Exhibit 4.1 of…

Methodology Note

• Priced-in inversion: the valuation is inverted on the current price to recover the operating-income growth, duration, and steady-state margin the price embeds (ROE for financials, FFO growth for REITs).
• Valuation x-ray: the valuation models, grouped into four families (asset, earnings, relative, growth). Each model is expressed as a price/FV ratio (distance from price), not a point fair-value estimate. The spread across families is the disagreement.
• Economic-unit decomposition (SOTP): each disclosed business unit is assigned its native valuation basis before any multiple is applied. Operating units are valued on enterprise value; funded financial units are valued on their own common equity, because their borrowings fund earning assets rather than levering the parent. A company total is stated only once every material unit carries a supported value and the parent capital bridge reconciles.
• Solvency: net cash/debt, net-debt-to-NOPAT, interest coverage, and share-count CAGR from EDGAR financials (net debt / FFO and fixed-charge coverage for REITs; regulatory-capital framing for financials).
• Peer cohorts: per-segment comparables with deep-linkable SEC filing citations.

Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.